505 related articles for article (PubMed ID: 25626880)
1. 3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.
Anneken JH; Angoa-Pérez M; Kuhn DM
J Neurochem; 2015 Apr; 133(2):211-22. PubMed ID: 25626880
[TBL] [Abstract][Full Text] [Related]
2. Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter.
Cameron KN; Kolanos R; Solis E; Glennon RA; De Felice LJ
Br J Pharmacol; 2013 Apr; 168(7):1750-7. PubMed ID: 23170765
[TBL] [Abstract][Full Text] [Related]
3. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum.
Angoa-Pérez M; Kane MJ; Francescutti DM; Sykes KE; Shah MM; Mohammed AM; Thomas DM; Kuhn DM
J Neurochem; 2012 Mar; 120(6):1097-107. PubMed ID: 22191803
[TBL] [Abstract][Full Text] [Related]
4. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA.
Angoa-Pérez M; Kane MJ; Briggs DI; Francescutti DM; Sykes CE; Shah MM; Thomas DM; Kuhn DM
J Neurochem; 2013 Apr; 125(1):102-10. PubMed ID: 23205838
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic Effects of Major Bath Salt Constituents 3,4-Methylenedioxypyrovalerone (MDPV), Mephedrone, and Methylone Are Enhanced Following Co-exposure.
Allen SA; Tran LH; Oakes HV; Brown RW; Pond BB
Neurotox Res; 2019 Jul; 36(1):132-143. PubMed ID: 30879275
[TBL] [Abstract][Full Text] [Related]
6. The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity.
Miner NB; O'Callaghan JP; Phillips TJ; Janowsky A
Neurotoxicol Teratol; 2017 May; 61():74-81. PubMed ID: 28212938
[TBL] [Abstract][Full Text] [Related]
7. Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption.
Blum K; Foster Olive M; Wang KK; Febo M; Borsten J; Giordano J; Hauser M; Gold MS
Med Hypotheses; 2013 Sep; 81(3):450-5. PubMed ID: 23845561
[TBL] [Abstract][Full Text] [Related]
8. Atypical dopamine efflux caused by 3,4-methylenedioxypyrovalerone (MDPV) via the human dopamine transporter.
Shekar A; Aguilar JI; Galli G; Cozzi NV; Brandt SD; Ruoho AE; Baumann MH; Matthies HJG; Galli A
J Chem Neuroanat; 2017 Oct; 83-84():69-74. PubMed ID: 28163218
[TBL] [Abstract][Full Text] [Related]
9. Dissecting the Influence of Two Structural Substituents on the Differential Neurotoxic Effects of Acute Methamphetamine and Mephedrone Treatment on Dopamine Nerve Endings with the Use of 4-Methylmethamphetamine and Methcathinone.
Anneken JH; Angoa-Pérez M; Sati GC; Crich D; Kuhn DM
J Pharmacol Exp Ther; 2017 Mar; 360(3):417-423. PubMed ID: 28039330
[TBL] [Abstract][Full Text] [Related]
10. Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter.
Cameron K; Kolanos R; Vekariya R; De Felice L; Glennon RA
Psychopharmacology (Berl); 2013 Jun; 227(3):493-9. PubMed ID: 23371489
[TBL] [Abstract][Full Text] [Related]
11. "Polytox" synthetic cathinone abuse: A potential role for organic cation transporter 3 in combined cathinone-induced efflux.
Mayer FP; Schmid D; Holy M; Daws LC; Sitte HH
Neurochem Int; 2019 Feb; 123():7-12. PubMed ID: 30248432
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxicology of Synthetic Cathinone Analogs.
Angoa-Pérez M; Anneken JH; Kuhn DM
Curr Top Behav Neurosci; 2017; 32():209-230. PubMed ID: 27753008
[TBL] [Abstract][Full Text] [Related]
13. Reinforcing and neurochemical effects of the "bath salts" constituents 3,4-methylenedioxypyrovalerone (MDPV) and 3,4-methylenedioxy-N-methylcathinone (methylone) in male rats.
Schindler CW; Thorndike EB; Goldberg SR; Lehner KR; Cozzi NV; Brandt SD; Baumann MH
Psychopharmacology (Berl); 2016 May; 233(10):1981-90. PubMed ID: 26319160
[TBL] [Abstract][Full Text] [Related]
14. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
Baumann MH; Partilla JS; Lehner KR; Thorndike EB; Hoffman AF; Holy M; Rothman RB; Goldberg SR; Lupica CR; Sitte HH; Brandt SD; Tella SR; Cozzi NV; Schindler CW
Neuropsychopharmacology; 2013 Mar; 38(4):552-62. PubMed ID: 23072836
[TBL] [Abstract][Full Text] [Related]
15. Mephedrone, methylone and 3,4-methylenedioxypyrovalerone (MDPV) induce conditioned place preference in mice.
Karlsson L; Andersson M; Kronstrand R; Kugelberg FC
Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):411-6. PubMed ID: 24739011
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of β-Keto Amphetamines: Deathly Mechanisms Elicited by Methylone and MDPV in Human Dopaminergic SH-SY5Y Cells.
Valente MJ; Bastos ML; Fernandes E; Carvalho F; Guedes de Pinho P; Carvalho M
ACS Chem Neurosci; 2017 Apr; 8(4):850-859. PubMed ID: 28067045
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined treatment with mephedrone and methamphetamine or 3,4-methylenedioxymethamphetamine on serotonin nerve endings of the hippocampus.
Angoa-Pérez M; Kane MJ; Herrera-Mundo N; Francescutti DM; Kuhn DM
Life Sci; 2014 Feb; 97(1):31-6. PubMed ID: 23892197
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters.
Magee CP; German CL; Siripathane YH; Curtis PS; Anderson DJ; Wilkins DG; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2020 Aug; 374(2):273-282. PubMed ID: 32385092
[TBL] [Abstract][Full Text] [Related]
19. Metabolites of the ring-substituted stimulants MDMA, methylone and MDPV differentially affect human monoaminergic systems.
Luethi D; Kolaczynska KE; Walter M; Suzuki M; Rice KC; Blough BE; Hoener MC; Baumann MH; Liechti ME
J Psychopharmacol; 2019 Jul; 33(7):831-841. PubMed ID: 31038382
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine + MDMA mixture.
Harvey EL; Baker LE
Psychopharmacology (Berl); 2016 Feb; 233(4):673-80. PubMed ID: 26558618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
